Immunoglobulin Treatment and Immune Health in Antibody Deficiency
Part of Genetic & congenital, Immune system & allergy clinical trials.
This study examines how well immunoglobulin replacement therapy works in people with primary antibody immunodeficiency—a rare condition where the body cannot make enough antibodies to fight infections. Researchers will also study immune system changes to understand treatment response better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with primary antibody immunodeficiency (a condition where your body doesn't make enough antibodies, confirmed by blood tests)
- Your immunoglobulin levels (IgG, IgA, and/or IgM) are below normal for your age, or you don't respond well to vaccines
- You are between 5 and 50 years old
- You are currently receiving or about to start regular immunoglobulin replacement therapy (infusions or injections)
- You do not have cancer, HIV, severe kidney or bowel disease, or other conditions that damage the immune system
- You are not pregnant, breastfeeding, or taking immune-suppressing medications (except your immunoglobulin therapy)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine (BP-SCIG 20%) given under the skin to help children and adults with primary immunodeficiency who have trouble making antibodies. It aims to see if the medicine is safe and works well to prevent infections.
This study is a safety check for people with primary immunodeficiency who are already using a specific immune globulin treatment given under the skin. It looks at medical records to see if any side effects occurred.
This trial tests a new intravenous immunoglobulin (IVIG) treatment for patients with primary immunodeficiency diseases, such as common variable immune deficiency (CVID) or X-linked agammaglobulinemia (XLA). It aims to see if this medicine is safe and works well to prevent infections.
This study collects blood (and sometimes related samples) to learn how genes and the immune system work in people with primary immunodeficiency (PID) or in family members who may not have it. The goal is to improve understanding of rare immune conditions and help guide future care.
This study tests if a moderate exercise program can help people with certain antibody deficiencies. It aims to see if exercise improves immune function in people who are not taking immunoglobulin therapy.
This study looks at what is happening in the immune system for people with an inherited (primary) immune problem. It may help researchers better understand the disease and how it works.
Hear when a new Primary Immunodeficiency Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.